• Home
  • Latest
  • Fortune 500
  • Finance
  • Tech
  • Leadership
  • Lifestyle
  • Rankings
  • Multimedia
Jason Gale

Stay informed with Jason Gale’s coverage and analysis.

Pfizer COVID vaccine booster cuts infection risk by 70% or more in Israel study
HealthPfizer COVID vaccine booster cuts infection risk by 70% or more in Israel study
By Jason Gale and BloombergSeptember 1, 2021
Belgian data finds that Moderna’s COVID vaccine creates twice as many antibodies as Pfizer’s
HealthBelgian data finds that Moderna’s COVID vaccine creates twice as many antibodies as Pfizer’s
By Jason Gale and BloombergAugust 31, 2021
An Israeli study finds that a COVID booster shot curbs the risk of serious illness
HealthAn Israeli study finds that a COVID booster shot curbs the risk of serious illness
By Jason Gale and BloombergAugust 30, 2021
Booster shots may be crucial for stopping spread of Delta variant, scientists say
HealthBooster shots may be crucial for stopping spread of Delta variant, scientists say
By Jason Gale and BloombergAugust 23, 2021
This is why vaccinated people are still testing positive for COVID-19
HealthThis is why vaccinated people are still testing positive for COVID-19
By Jason Gale and BloombergJuly 22, 2021
Alpha bad, Delta worse—and Lambda? Why each new COVID variant causes so much alarm
HealthAlpha bad, Delta worse—and Lambda? Why each new COVID variant causes so much alarm
By Jason Gale and BloombergJuly 8, 2021
COVID leads to an rise in patients getting a rare medical procedure: double-lung transplants
HealthCOVID leads to an rise in patients getting a rare medical procedure: double-lung transplants
By Jason Gale and BloombergJune 18, 2021
‘Hard to believe’: Scientists alarmed by COVID’s diabetes link, particularly in children
Health‘Hard to believe’: Scientists alarmed by COVID’s diabetes link, particularly in children
By Jason Gale and BloombergMay 5, 2021
AstraZeneca’s U.S. COVID trial in doubt after agency says drugmaker may have submitted outdated data
HealthAstraZeneca’s U.S. COVID trial in doubt after agency says drugmaker may have submitted outdated data
By Michelle Fay Cortez, Jason Gale and BloombergMarch 23, 2021
SWITZERLAND-CHINA-DRCONGO-WHO-HEALTH-EPIDEMIC-EBOLA-VIRUS
HealthNew COVID vaccines that don’t require needles could be ready later this year, WHO says
By Jason Gale and BloombergMarch 16, 2021
After just one dose of the Pfizer-BioNTech vaccine, hospitalizations are down 92%, Israeli study shows
HealthAfter just one dose of the Pfizer-BioNTech vaccine, hospitalizations are down 92%, Israeli study shows
By Naomi Kresge, Jason Gale and BloombergFebruary 25, 2021
The U.K. plans to infect young volunteers with COVID-19 to learn more about the virus
HealthThe U.K. plans to infect young volunteers with COVID-19 to learn more about the virus
By Jason Gale and BloombergFebruary 18, 2021
What you need to know about severe reactions to COVID vaccines
HealthWhat you need to know about severe reactions to COVID vaccines
By John Lauerman, Jason Gale and BloombergFebruary 15, 2021
COVID vaccine second shot, dose
HealthWhat to know about delaying second COVID vaccine shots as countries grapple with limited supplies
By John Lauerman, Jason Gale and BloombergJanuary 26, 2021
Pfizer BioNTech vaccine may be effective against fast-spreading COVID-19 variants, study says
HealthPfizer BioNTech vaccine may be effective against fast-spreading COVID-19 variants, study says
By Jeff Sutherland, Jason Gale and BloombergJanuary 8, 2021
1
  • 1
  • 2
  • 3
  • 4
4
Most Popular
Success
Gen Zers are arriving at college unable to even read a sentence—professors warn it could lead to a generation of anxious and lonely graduatesplaceholder alt text
By Preston ForeJune 7, 2026
Economy
'We didn’t see this coming': Wall Street eats its forecasts as stocks sell off globally on fear of AI bubble ahead of SpaceX IPOplaceholder alt text
By Jim EdwardsJune 8, 2026
Economy
'The golden years are not golden': Boomers are hoarding most of America's wealth and power because they're terrified of outliving their moneyplaceholder alt text
By Nick LichtenbergJune 7, 2026
Fortune Secondary Logo
Rankings
  • 100 Best Companies
  • Fortune 500
  • Global 500
  • Fortune 500 Europe
  • Most Powerful Women
  • World's Most Admired Companies
  • See All Rankings
  • Lists Calendar
Sections
  • Finance
  • Fortune Crypto
  • Features
  • Leadership
  • Health
  • Commentary
  • Success
  • Retail
  • Mpw
  • Tech
  • Lifestyle
  • CEO Initiative
  • Asia
  • Politics
  • Conferences
  • Europe
  • Newsletters
  • Personal Finance
  • Environment
  • Magazine
  • Education
Customer Support
  • Frequently Asked Questions
  • Customer Service Portal
  • Privacy Policy
  • Terms Of Use
  • Single Issues For Purchase
  • International Print
Commercial Services
  • Advertising
  • Fortune Brand Studio
  • Fortune Analytics
  • Fortune Conferences
  • Business Development
  • Group Subscriptions
About Us
  • About Us
  • Press Center
  • Work At Fortune
  • Terms And Conditions
  • Site Map
  • About Us
  • Press Center
  • Work At Fortune
  • Terms And Conditions
  • Site Map
  • Facebook icon
  • Twitter icon
  • LinkedIn icon
  • Instagram icon
  • Pinterest icon

© 2026 Fortune Media IP Limited. All Rights Reserved. Use of this site constitutes acceptance of our Terms of Use and Privacy Policy | CA Notice at Collection and Privacy Notice | Do Not Sell/Share My Personal Information
FORTUNE is a trademark of Fortune Media IP Limited, registered in the U.S. and other countries. FORTUNE may receive compensation for some links to products and services on this website. Offers may be subject to change without notice.